Nisa Investment Advisors’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.68K | Buy |
919
+564
| +159% | +$2.26K | ﹤0.01% | 2499 |
|
2025
Q1 | $323 | Buy |
+355
| New | +$323 | ﹤0.01% | 2864 |
|
2024
Q4 | – | Sell |
-179
| Closed | -$936 | – | 3026 |
|
2024
Q3 | $936 | Buy |
179
+164
| +1,093% | +$858 | ﹤0.01% | 2595 |
|
2024
Q2 | $67 | Sell |
15
-9
| -38% | -$40 | ﹤0.01% | 2892 |
|
2024
Q1 | $184 | Buy |
+24
| New | +$184 | ﹤0.01% | 2654 |
|
2022
Q3 | – | Sell |
-4,800
| Closed | -$23K | – | 2610 |
|
2022
Q2 | $23K | Buy |
+4,800
| New | +$23K | ﹤0.01% | 2013 |
|
2021
Q4 | – | Sell |
-200
| Closed | -$2 | – | 2281 |
|
2021
Q3 | $2 | Hold |
200
| – | – | ﹤0.01% | 2291 |
|
2021
Q2 | $3 | Buy |
+200
| New | +$3 | ﹤0.01% | 2294 |
|